Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection

Valerie Greco-Stewart, Jeffrey Kiernan, Donna Killeen, Sherry Haun, Dena Mercer, Kimberly Young, Robert S. Liwski, David S. Allan

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

BACKGROUND: Utilization of unrelated donors and cord blood units (CBUs) for allogeneic hematopoietic cell transplantation continues to increase. Understanding the practices of donor selection by transplant centers is critical for unrelated donor registries and cord blood banks to optimize registry composition and inventory to meet patient need. STUDY DESIGN AND METHODS: Unrelated donor and CBU selection practices of Canadian transplant centers served by Canadian Blood Services' OneMatch Stem Cell & Marrow Network (OM) were reviewed, including HLA match level, locus of disparity, age, sex, and product choice (donor vs. CBU). RESULTS: HLA-matched donors within OM and/or international (INT) registries were preferentially investigated, underscoring the primary importance of HLA matching. In the case of HLA-mismatched donors, HLA-A disparities were most common while DRB1 mismatches were least common. Advanced age, sex, and lack of donor availability were the most frequent reasons that high-probability OM donors were overlooked in favor of INT donors. High-probability 10 of 10 HLA-matched female donors from OM were often avoided in favor of INT male donors. Use of female donors, however, increased in cases restricted to more HLA-disparate donor options. Caucasian patients were more likely to find 10 of 10 matched donors, whereas use of mismatched donors and CBUs were more prevalent among non-Caucasian patients. CONCLUSIONS: Recruitment and retention of young, male donors from diverse ethnic backgrounds may increase the usage of histocompatible OM donors for patients in need.

Original languageEnglish
Pages (from-to)718-725
Number of pages8
JournalTransfusion
Volume58
Issue number3
DOIs
Publication statusPublished - Mar 2018

Bibliographical note

Funding Information:
From the 1OneMatch Stem Cell & Marrow Network, Canadian Blood Services; the 2Centre for Transfusion Research; the 5Ottawa Hospital Research Institute, and the 6Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada; 3University Health Network, Toronto, Ontario, Canada; the 4Departments of Pathology and Microbiology & Immunology, Dalhousie University, Halifax, Nova Scotia, Canada. Address reprint requests to: Dr David Allan, MD, FRCPC, c/o The Ottawa Hospital, 501 Smyth Road, Box 704, Ottawa, ON, Canada K1H 8L6; e-mail: daallan@ohri.ca. VGS and JK have contributed equally to this work. JK was supported by the Centre for Transfusion Research at The Ottawa Hospital and DSA is supported by the Department of Medicine at the University of Ottawa. Received for publication August 4, 2017; revision received October 20, 2017; and accepted October 24, 2017. doi:10.1111/trf.14458 VC 2017 AABB TRANSFUSION 2018;58;718–725

Publisher Copyright:
© 2017 AABB

ASJC Scopus Subject Areas

  • Immunology and Allergy
  • Immunology
  • Hematology

PubMed: MeSH publication types

  • Evaluation Study
  • Journal Article
  • Research Support, Non-U.S. Gov't

Fingerprint

Dive into the research topics of 'Unrelated donor choices for allogeneic hematopoietic cell transplantation in Canada: an evaluation of factors influencing donor selection'. Together they form a unique fingerprint.

Cite this